Corbus Pharmaceuticals Holdings, Inc. Financial Ratios — CRBP

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-73.57	-90.89	-130.02	-76.41	-97.7	-148.66	-146.95	-43.46	-48.66	-94.32	-43.67	-48.47
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	100	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	-1,358.73	-1,040.97	-1,323.96	-1,166.54	-209.93	-3,076.17	-6,164.17	- -	- -	- -	- -
Operating Margin (%)	- -	- -	-1,365.51	-1,045.56	-1,334.43	-1,176.78	-213.33	-3,119.2	-6,350.09	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2,399.17	- -	- -	- -
Pretax Margin (%)	- -	- -	-1,365.05	-1,046.27	-1,328.65	-1,154.48	-197.69	-2,826.08	-5,176.38	- -	- -	- -	- -
Profit Margin (%)	- -	- -	-1,365.05	-1,046.27	-1,328.65	-1,154.48	-197.69	-2,826.08	-5,176.38	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	-1,365.05	-1,046.27	-1,328.65	-1,154.48	-197.69	-2,826.08	-5,176.38	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	1	- -	- -	- -	- -	- -	9	27	27	25	21	3	2
ST Debt	- -	- -	- -	- -	- -	- -	1	2	5	4	18	2	2
LT Debt	- -	- -	- -	- -	- -	- -	8	25	22	21	3	2	- -
Total Debt/EBITDA	-1.14	-0.05	-0.02	-0.01	-0.01	-0.01	-0.12	-0.22	-0.49	-0.74	-0.47	-0.07	-0.02
Net Debt/EBITDA	-0.6	2.32	1.38	0.74	1.93	0.74	0.41	0.55	0.1	-0.06	-0.06	0.36	0.33
Total Debt/EBIT	-1.14	-0.05	-0.02	-0.01	-0.01	-0.01	-0.12	-0.22	-0.47	-0.72	-0.46	-0.07	-0.02
Net Debt/EBIT	-0.6	2.31	1.38	0.74	1.91	0.73	0.4	0.54	0.1	-0.06	-0.06	0.35	0.33
EBITDA to Interest Expense	-12.35	-109.77	-3,610.55	- -	- -	- -	- -	- -	- -	- -	-11.52	-25.71	- -
EBITDA-CapEx/Interest Expense	-12.35	-112.45	-3,657.29	- -	- -	- -	- -	- -	- -	- -	-11.52	-25.71	- -
EBIT to Interest Expense	-12.35	-110.2	-3,628.56	- -	- -	- -	- -	- -	- -	- -	-11.68	-26.03	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	2	- -
Common Equity/Total Assets	-617.27	-67.03	-103.1	-186	-98.08	-258.28	-392.36	-297.26	-324.64	-591.27	-1,544.58	-305.94	-330.23
Long-Term Debt/Equity (%)	- -	- -	- -	0.05	- -	- -	131.5	55.49	31.24	62.62	- -	1.15	- -
Long-Term Debt/Capital (%)	-26.55	- -	- -	-0.01	- -	- -	-4.42	-9.06	-6.68	-5.63	-0.78	-0.34	- -
Long-Term Debt/Total Assets (%)	108.42	- -	- -	0.03	- -	- -	16.48	24.56	20.04	31.16	11.46	1.05	- -
Total Debt/Equity (%)	-35.78	2.46	1.8	3.1	0.58	1.43	153.4	59.27	38.48	76.05	-302.46	2.27	1.11
Total Debt/Capital (%)	-51.14	-3.37	-1.24	-0.84	-0.51	-0.33	-5.15	-9.68	-8.23	-6.84	-5.02	-0.68	-0.29
Total Debt/Total Assets (%)	208.85	2.19	1.26	1.55	0.5	0.84	19.22	26.23	24.68	37.84	73.87	2.08	0.97
Net Debt to Equity	-18.79	-104.36	-135.52	-165.04	-107.65	-150.25	-503.38	-147.31	-7.97	6.46	-35.99	-12.07	-19.32
Net Debt/Capital (%)	-21.6	58.03	47.84	30.68	48.64	25.41	14.41	18.39	1.58	-0.55	-0.58	3.5	4.89
EBITDA	-1	-3	-9	-20	-32	-56	-76	-121	-54	-34	-44	-48	-85
EBITDA-CapEx	-1	-3	-9	-20	-33	-59	-79	-122	-54	-34	-44	-48	-85
Operating Income (Loss)	-1	-3	-9	-20	-33	-57	-77	-123	-56	-35	-45	-49	-85

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.47	8.49	3.4	1.68	7.62	2.31	0.91	2.68	5.74	4.68	0.66	12.61	7.89
Current Ratio	0.47	8.85	3.5	1.96	7.98	2.45	1.09	2.89	5.89	4.76	0.74	12.94	8.07
Quick Ratio	0.47	8.49	3.4	1.83	7.62	2.31	0.99	2.76	5.74	4.68	0.66	12.61	7.89
CFO/Avg Current Liab	- -	-3.41	-2.12	-2.17	-3.25	-2.29	-1.73	-2.99	-1.97	-2.53	-1.62	-1.91	-3.97
Common Equity/Total Assets	-617.27	-67.03	-103.1	-186	-98.08	-258.28	-392.36	-297.26	-324.64	-591.27	-1,544.58	-305.94	-330.23
Long-Term Debt/Equity (%)	- -	- -	- -	0.05	- -	- -	131.5	55.49	31.24	62.62	- -	1.15	- -
Long-Term Debt/Capital (%)	-26.55	- -	- -	-0.01	- -	- -	-4.42	-9.06	-6.68	-5.63	-0.78	-0.34	- -
Long-Term Debt/Total Assets (%)	108.42	- -	- -	0.03	- -	- -	16.48	24.56	20.04	31.16	11.46	1.05	- -
Total Debt/Equity (%)	-35.78	2.46	1.8	3.1	0.58	1.43	153.4	59.27	38.48	76.05	-302.46	2.27	1.11
Total Debt/Capital (%)	-51.14	-3.37	-1.24	-0.84	-0.51	-0.33	-5.15	-9.68	-8.23	-6.84	-5.02	-0.68	-0.29
Total Debt/Total Assets (%)	208.85	2.19	1.26	1.55	0.5	0.84	19.22	26.23	24.68	37.84	73.87	2.08	0.97
CFO/Total Liabilities	-17.56	-319.93	-118.88	-151.31	-302.31	-154.47	-106.36	-174.83	-124.76	-112.67	-102.62	-310.71	-311.67
CFO/CapEx	- -	-36.64	-40.56	-38.44	-39.29	-13.07	-16.67	-205.75	-889.46	-2,791.62	- -	- -	-9,213
Altman's Z-Score	-16.01	47.79	5.16	17.64	21.33	3.43	-4.99	-6.35	-4.15	-8.9	-26.79	1.52	-2.11

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	3.82	4.88	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	95.48	74.79	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	60	52	348	356	333	349	98	76	14	26	129	108
- Cash & Cash Equivalents	- -	6	12	15	63	42	32	85	25	17	14	17	28
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	- -	- -	- -	- -	- -	9	27	27	25	21	3	2
Enterprise Value	- -	54	40	333	294	292	327	39	5	-20	26	-17	-53
Total Capital	-1	-4	-13	-33	-65	-121	-183	-277	-323	-367	-416	-474	-554
Total Debt/Capital (%)	-51.14	-3.37	-1.24	-0.84	-0.51	-0.33	-5.15	-9.68	-8.23	-6.84	-5.02	-0.68	-0.29
Total Debt / EV	1.9	- -	- -	- -	- -	- -	0.03	0.69	5.65	-1.24	0.8	-0.19	-0.03
EV/Sales	- -	- -	61	174.16	120.5	60.45	9.04	9.92	5.34	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	60	52	348	356	333	349	98	76	14	26	129	108
Diluted Enterprise Value	- -	54	40	333	294	292	327	39	77	22	33	115	82
EV per Share	0.39	80.6	37.85	242.77	175.81	153.43	153.33	15	1.15	- -	6.04	- -	- -
TTM Sales	- -	- -	1	2	2	5	36	4	1	- -	- -	- -	- -
TTM EBITDA	-1	-3	-9	-20	-32	-56	-76	-121	-54	-34	-44	-48	-85
TTM Operating Income	-1	-3	-9	-20	-33	-57	-77	-123	-56	-35	-45	-49	-85
TTM Cash Flow to Firm	- -	-2	-5	-14	-28	-30	-46	-100	-48	-38	-32	-40	-64
TTM Free Cash Flow to Firm	- -	-2	-5	-13	-27	-28	-43	-99	-48	-38	-32	-40	-64

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	-26.24	-11.47	-26.3	-13.15	-11.99	-8.12	-0.98	-1.57	-0.37	-0.72	-3.08	-1.68
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	54	40	333	294	292	327	39	5	-20	26	-17	-53
Low Price	- -	81.3	43.47	30.3	159	135	125.4	27.3	17.7	3	2.11	5.67	4.64
EV/Sales	- -	- -	61	174.16	120.5	60.45	9.04	9.92	5.34	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-26.1	-8.63	-8.19	-10.97	-6.54	-5.62	-3.44	-4.19	-0.83	-0.62	-9.16	-1.61
Price/Earnings High	- -	-39.28	-15.27	-22.17	-16.25	-10.19	-8.15	-6.87	-10.78	-1.98	-1.28	-16.8	-3.49
Price/Earnings Low	- -	-21.51	-5.13	-2.08	-8.2	-4.61	-3.74	-0.64	-1.59	-0.3	-0.2	-1.54	-0.79
Price/Book Value	- -	-13.62	-3.9	-10.45	-5.42	-2.74	-1.81	-0.32	-0.22	-0.04	-0.06	-0.27	-0.2
Price/Book Value Average	- -	-14.99	-5.75	-4.92	-5.41	-3	-2.08	-1.26	-0.55	-0.09	-0.06	-0.77	-0.23
Price/Book Value High	- -	-22.55	-10.18	-13.33	-8.02	-4.68	-3.02	-2.51	-1.41	-0.21	-0.13	-1.42	-0.49
Price/Book Value Low	- -	-12.35	-3.42	-1.25	-4.05	-2.11	-1.39	-0.23	-0.21	-0.03	-0.02	-0.13	-0.11
Price/Tangible Book Value	- -	10.28	5.76	38.97	6.17	12.09	56.66	2.16	1.1	0.42	-3.79	0.9	0.73
Price/Tangible Book Value Average	- -	11.31	8.5	18.37	6.16	13.22	65.27	8.46	2.77	1.07	-4.02	2.59	0.86
Price/Tangible Book Value High	- -	17.02	15.04	49.72	9.12	20.62	94.54	16.88	7.12	2.54	-8.25	4.74	1.86
Price/Tangible Book Value Low	- -	9.32	5.06	4.66	4.6	9.32	43.38	1.57	1.05	0.38	-1.32	0.43	0.42
Price/Sales	- -	- -	79.78	181.86	146	69.03	9.65	24.81	85.93	- -	- -	- -	- -
Price/Sales Average	- -	- -	117.75	85.72	145.76	75.48	11.12	97.25	217.05	- -	- -	- -	- -
Price/Sales High	- -	- -	208.39	232.01	215.91	117.67	16.11	194.08	557.96	- -	- -	- -	- -
Price/Sales Low	- -	- -	70.06	21.74	108.98	53.19	7.39	18.06	82.3	- -	- -	- -	- -
Price/Cash Flow	- -	-25.53	-11.18	-25.61	-12.82	-11.07	-7.63	-0.98	-1.57	-0.37	-0.72	-3.08	-1.68
Price/Cash Flow Average	- -	-28.08	-16.51	-12.07	-12.8	-12.11	-8.79	-3.84	-3.97	-0.94	-0.77	-8.81	-1.96
Price/Cash Flow High	- -	-42.26	-29.22	-32.68	-18.95	-18.87	-12.73	-7.67	-10.21	-2.23	-1.58	-16.17	-4.25
Price/Cash Flow Low	- -	-23.14	-9.82	-3.06	-9.57	-8.53	-5.84	-0.71	-1.51	-0.33	-0.25	-1.48	-0.96
Price/Free Cash Flow Average	- -	-28.87	-16.93	-12.4	-13.13	-13.11	-9.35	-3.86	-3.98	-0.94	-0.77	-8.81	-1.96
Price/Free Cash Flow High	- -	-43.45	-29.95	-33.55	-19.45	-20.44	-13.54	-7.7	-10.22	-2.23	-1.58	-16.17	-4.25
Price/Free Cash Flow Low	- -	-23.79	-10.07	-3.14	-9.82	-9.24	-6.21	-0.72	-1.51	-0.33	-0.25	-1.48	-0.96
EV/Sales Average	- -	- -	98.97	78.03	120.27	66.9	10.5	82.36	218.85	- -	- -	- -	- -
EV/Sales High	- -	- -	189.61	224.31	190.42	109.09	15.49	179.2	559.76	- -	- -	- -	- -
EV/Sales Low	- -	- -	51.28	14.04	83.49	44.61	6.77	3.18	84.1	- -	- -	- -	- -
EV/EBITDA Average	-0.6	-22.83	-7.28	-7.5	-9.08	-5.74	-5	-2.68	-3.55	-1.27	-0.79	-7.36	-1.17
EV/EBITDA High	-0.6	-35.53	-13.96	-21.55	-14.38	-9.35	-7.38	-5.83	-9.08	-2.7	-1.44	-13.75	-2.9
EV/EBITDA Low	-0.6	-18.4	-3.77	-1.35	-6.31	-3.82	-3.23	-0.1	-1.36	-0.6	-0.37	-1	-0.41
EV/EBIT Average	-0.6	-22.74	-7.25	-7.46	-9.01	-5.69	-4.92	-2.64	-3.45	-1.24	-0.77	-7.27	-1.17
EV/EBIT High	-0.6	-35.39	-13.89	-21.45	-14.27	-9.27	-7.26	-5.75	-8.82	-2.64	-1.42	-13.58	-2.89
EV/EBIT Low	-0.6	-18.33	-3.76	-1.34	-6.26	-3.79	-3.17	-0.1	-1.32	-0.59	-0.36	-0.98	-0.41
Last Price	- -	89.7	49.5	253.5	213	175.2	163.8	37.5	18.48	3.33	6.04	11.8	8.14
High Price	- -	148.5	129.3	323.4	315	298.65	273.3	293.4	120	20.1	13.17	61.9	20.56
Enterprise Value Average	- -	60	64	149	293	323	380	324	193	43	35	354	100
Enterprise Value High	- -	94	123	429	465	526	560	706	494	92	64	662	247
Enterprise Value Low	- -	49	33	27	204	215	245	13	74	21	16	48	35

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	1	1	1	1	2	2	2	3	4	4	4	12	18
Diluted Weighted Avg Shares	1	1	1	1	2	2	2	3	4	4	4	11	13
Basic Weighted Avg Shares	1	1	1	1	2	2	2	3	4	4	4	11	13
Revenue per Share	- -	- -	0.62	1.39	1.46	2.54	16.97	1.51	0.22	- -	- -	- -	- -
EBITDA per Share	-0.65	-3.92	-8.43	-14.51	-19.32	-29.61	-35.62	-46.5	-13.26	-8.17	-10.27	-4.41	-6.39
Operating Income per Share	-0.65	-3.94	-8.47	-14.57	-19.47	-29.87	-36.2	-47.15	-13.66	-8.35	-10.42	-4.46	-6.41
Basic EPS, GAAP	-0.7	-3.78	-8.47	-14.58	-19.38	-29.3	-33.55	-42.72	-11.13	-10.15	-10.31	-3.68	-5.9
Basic EPS from Cont Ops	-0.7	-3.78	-8.47	-14.58	-19.38	-29.3	-33.55	-42.72	-11.13	-10.15	-10.31	-3.68	-5.9
Diluted EPS, GAAP	-0.7	-3.78	-8.47	-14.58	-19.38	-29.3	-33.55	-42.72	-11.13	-10.15	-10.31	-3.68	-5.9
Diluted EPS from Cont Ops	-0.7	-3.78	-8.47	-14.58	-19.38	-29.3	-33.55	-42.72	-11.13	-10.15	-10.31	-3.68	-5.9
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.43	-3.51	-4.43	-9.9	-16.62	-15.82	-21.47	-38.28	-11.75	-9	-8.34	-3.83	-4.84
Free Cash Flow per Basic Share	-0.43	-3.61	-4.53	-10.15	-17.04	-17.04	-22.75	-38.46	-11.77	-9.01	-8.34	-3.83	-4.84
Cash & Equivalents per Share	0.35	9.32	11.81	10.93	37.39	21.97	14.91	32.8	23.82	14.19	4.83	13.66	12.26
Book Value per Share	-2.19	-6.58	-12.7	-24.26	-39.28	-63.88	-90.53	-116.76	-85.31	-94.01	-100.91	-43.69	-41.71
Tangible Book Value per Share	-2.07	8.72	8.6	6.5	34.55	14.49	2.89	17.38	16.86	7.91	-1.6	13.05	11.08

Corbus Pharmaceuticals Holdings, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)